Aixa E Soyano-Muller

Real‐world benefit of combination palbociclib and endocrine therapy for metastatic breast cancer and correlation with neutropenia

James X. Sun, B. Czerniecki, S. Hoover, 2021, Cancer medicine.

Durable Complete Response With Immune Checkpoint Inhibitor in Breast Cancer With High Tumor Mutational Burden and APOBEC Signature.

E. Thompson, E. Sokol, A. Nassar, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Effects of Age and Immune Landscape on Outcome in HER2-Positive Breast Cancer in the NCCTG N9831 (Alliance) and NSABP B-31 (NRG) Trials

D. Serie, E. Perez, E. Thompson, 2019, Clinical Cancer Research.

IRIS METASTASIS FROM BREAST CANCER SUCCESSFULLY TREATED WITH ABEMACICLIB AND LETROZOLE

J. Harbour, Z. Corrêa, Lediana Goduni, 2021, Retinal cases & brief reports.